Biography
Ms. Varanasi is a co-founder, President and CEO of X-Biotix. She is an accomplished business executive, with 24 years of biopharmaceutical industry experience and a distinguished track record in structuring, negotiating and executing successful strategic alliances, licensing agreements and M&A transactions as well as providing business development, management and strategic leadership to organizations. She has held Research and senior level positions in Business & Corporate Development including at Merck, Millennium (now Takeda), Momenta, and Checkmate Pharmaceuticals, to name a few. Over the course of her career, Ramani has been involved in the formation of strategic partnerships with companies and research organizations globally, including in emerging markets such as Asia - and continues to have a keen interest in bridging the research and business gap and fostering collaboration between enterprises in this global marketplace. Her broad experience in the areas of early stage company formation and financing, including dilutive and non-diluting funding initiatives, has enabled her to execute deals with total value in excess of several billion dollars. Ramani holds a B.Sc. and a M.Sc. from McGill University in Microbiology & Immunology and Biochemistry, respectfully, and an MBA in General Strategy from Northeastern University. She volunteers as a mentor to start-up companies in the biopharma area and also has an avid interest in the area of international healthcare, a sector in which she has been involved as a board member for two non-profit organizations.
Industry Expertise (2)
Biotechnology
Pharmaceuticals
Areas of Expertise (9)
Clinical Trials
Molecular Biology
Oncology
Pharmaceutical Industry
Biotechnology
Life Sciences
Drug Development
Technology Transfer
Biopharmaceuticals
Education (2)
McGill University: M.Sc., Biochemistry and Molecular Biology
McGill University: B.Sc., Microbiology and Immunology
Multimedia
Publications:
Documents:
Audio/Podcasts:
Affiliations (1)
- Executive Women In Bio
Links (1)
Selected Media Appearances (2)
X-Biotix Therapeutics Announces Corporate Progress and Successful Fundraise
Business Wire online
2019-11-13
“I am extremely pleased about securing additional funding for X-Biotix and I welcome Mr. Bonney, a luminary in the industry and an expert in the field, as a formal advisor to the team,” said Ramani Varanasi, President & CEO of X-Biotix Therapeutics. “The X-Biotix team has delivered on multiple development milestones, and the extension of Series A financing is a reflection of that progress. Access to additional capital, combined with Mike’s leadership and broad expertise in the antibiotics area will be invaluable as we advance our pipeline of novel antibiotics to address the critical public health need for new approaches to treat drug resistant pathogens."
Executive Women In Bio Selects Candidates for 2019 Boardroom Ready Program
Globe News Wire online
2019-07-18
The 2019 participants join a strong community of ambitious program alumnae, who have earned 35 boardroom appointments since the program’s inception in 2016. The candidates selected for this year’s Boardroom Ready program are: - Ramani Varanasi, MS, MBA – Co-founder, President, and CEO, X-Biotix Therapeutics..
Social